Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
GW Pharmaceuticals will have its cannabidiol for seizures, Epidiolex, looked at by the Eruopean Medicines Agency
February 5, 2018 Off

GW Pharmaceuticals will have its cannabidiol for seizures, Epidiolex, looked at by the Eruopean Medicines Agency

By Dino Mustafić

GW Pharmaceuticals, a biopharmaceutical company focused on making and selling therapeutics from its cannabinoid product platform, said Monday that the…

Shire shares findings on lysosomal disease areas in San Diego
February 5, 2018 Off

Shire shares findings on lysosomal disease areas in San Diego

By Dino Mustafić

Shire said on Monday that it will have 12 presentations at the 14th annual WORLDSymposium 2018 in San Diego, in…

February 5, 2018 Off

Nymox plans submitting NDA for Fexapotide Triflutate, to treat BPH in US

By Dino Mustafić

Nymox Pharmaceutical will submit a New Drug Application (NDA) for Fexapotide Triflutate for the treatment of BPH in the US,…

Adventist Health gets “A” Rating, positive outlook from Fitch Ratings
February 4, 2018 Off

Adventist Health gets “A” Rating, positive outlook from Fitch Ratings

By Dino Mustafić

Adventist Health—a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—has received a positive…

Interview: Elena Piazza, Business Development and Marketing Manager at Bormioli Pharma
February 3, 2018 Off

Interview: Elena Piazza, Business Development and Marketing Manager at Bormioli Pharma

By Dino Mustafić

As a media partner for this year’s Pharmapack event in Paris, Pharmaceutical Daily has interviewed Elena Piazza, Business Development and…

Spang&Brands to showcase plastic primary packaging for pharmaceuticals
February 3, 2018 Off

Spang&Brands to showcase plastic primary packaging for pharmaceuticals

By Dino Mustafić

At Pharmapack in Paris, Spang & Brands is going to spotlight two innovative pharmaceutical devices: A single-use nasal dosing device…

FDA says “OK” to Allergan’s NDA for expanded use of hospital-acquired bacterial pneumonia AVYCAZ
February 2, 2018 Off

FDA says “OK” to Allergan’s NDA for expanded use of hospital-acquired bacterial pneumonia AVYCAZ

By Dino Mustafić

Allergan’s supplemental New Drug Application (sNDA) to expand the approved use of AVYCAZ has gotten the FDA’s approval.

After total revenue declined 2% in the year, AstraZeneca positioned for product sales growth from FY 2018
February 2, 2018 Off

After total revenue declined 2% in the year, AstraZeneca positioned for product sales growth from FY 2018

By Dino Mustafić

AstraZeneca’s revenues improved over the course of the year, Pascal Soriot, Chief Executive Officer, commenting on the results said on…

Pacific Biosciences posts net loss for Q4 and year 2017
February 2, 2018 Off

Pacific Biosciences posts net loss for Q4 and year 2017

By Dino Mustafić

Pacific Biosciences of California said in its fourth quarter results announcement that it has had 19% of increase in product, service…

Gilead sciences welcomes new board member
February 2, 2018 Off

Gilead sciences welcomes new board member

By Dino Mustafić

Gilead Sciences has appointed new member to its board of directors, Jacqueline K. Barton who has previously served on Gilead’s Scientific…

Posts pagination

Previous 1 … 3,408 3,409 3,410 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine